The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the European mantle cell lymphoma network

2024 . Fischer, Luca | Jiang, Linmiao | Dürig, Jan | Schmidt, Christian | Stilgenbauer, Stephan | Bouabdallah, Krimo | Solal-Celigny, Philippe | Scholz, Christian W. | Feugier, Pierre | de Wit, Maike | Trappe, Ralf Ulrich | Hallek, Michael | Graeven, Ullrich | Hänel, Mathias | Hoffmann, Martin | Delwail, Vincent | Macro, Margaret | Greiner, Jochen | Giagounidis, Aristoteles A. N. | Dargel, Beate | Durot, Eric | Foussard, Charles | Silkenstedt, Elisabeth | Weigert, Oliver | Pott, Christiane | Klapper, Wolfram | Hiddemann, Wolfgang | Unterhalt, Michael | Hoster, Eva | Ribrag, Vincent | Dreyling, Martin